<DOC>
	<DOCNO>NCT02005107</DOCNO>
	<brief_summary>This study conduct evaluate body absorbs process immediate release ( IR ) sustain release ( XR ) medication venlafaxine ( EffexorÂ® ) . Subject 1-3 year post gastric bypass sleeve gastrectomy surgery invite participate . Non-surgical control also enrol base match criterion post gastric bypass subject . Participants ask complete two 12-hour study day approximately 11 day apart . This study enroll 30 participant .</brief_summary>
	<brief_title>Venlafaxine PK Following Bariatric Surgery</brief_title>
	<detailed_description />
	<mesh_term>Venlafaxine Hydrochloride</mesh_term>
	<criteria>1 . Male Female 2 . Age 1865 ( inclusive , time informed consent ) 3 . No tobacco use past three month . 4 . Underwent RouxenY Gastric Bypass Sleeve Gastrectomy weight loss surgery 1236 month prior study OR weight loss surgery match gastric bypass patient age , gender , BMI . Criteria match establish begin study consultation statistical team address need input biostatistician . 5 . Ability read , write understand English 1 . Taking medication clinically significant interaction venlafaxine interaction may alter study data . 2 . Hypersensitivity venlafaxine excipient contain within dosage form 3 . Inability tolerate repeat blood draw . 4 . Any history bipoloar disorder psychotic disorder . 5 . Current major depressive disorder current suicidality . 6 . Alcohol substance dependence past year . 7 . Currently pregnant lactate unwillingness use medically accept contraception study 8 . Taking medication significantly alter gastrointesinal transit time significantly reduce acid secretion ( e.g . routine use proton pump inhibitor , H2 antagonists , sucralfate ) . 9 . Medical conditon may increase participant risk venlafaxine uncontrolled hypertension discretion examine provider . 10 . Hepatic insufficiency define hepatic enzyme great 3x upper limit normal hepatic laboratory abnormality discretion medical provider . 11 . Renal impairment evidence calculate creatinine clearance less equal 70ml/min abnormality renal panel medical provider feel put participant risk . 12 . Poor ultrarapid Cytochrome P450 2D6 metabolizer . 13 . Self report history viral hepatits HIV . 14 . Positive urine drug screen unless document prescription noninteracting medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>